Top Markets
Coin of the day
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rangering i aksjer #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-12
Markedsverdi
$124.11K
Endring (1 dag)
0.00%
Endring (1 år)
9,900.00%
Land
US
Handel GlobeStar Therapeutics Corporation (GSTC)

Kategori

Pris GSTC pris med markedsverdi på B
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
GSTC
$0.0001
Markedsverdi av GlobeStar Therapeutics Corporation(GSTC)
Markedsverdi: $124.11K
Per August 2026 har GlobeStar Therapeutics Corporation en markedsverdi på $124.11K. Dette gjør GlobeStar Therapeutics Corporation til det 40541st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for GlobeStar Therapeutics Corporation fra 2011 til 2026
GSTC sammenlignet med topp 5 mest populære stocks
Pris på GSTC Eiendel B Markedsverdi for B Resultater
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
$4,403.89 $124.11K
$5.466T +4,403,887,096.06%
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
$3,590.33 $124.11K
$4.456T +3,590,331,890.59%
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
$3,361.96 $124.11K
$4.173T +3,361,962,966.16%
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
$2,971.32 $124.11K
$3.688T +2,971,318,975.45%
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation
$2,308.11 $124.11K
$2.865T +2,308,107,641.21%